EC
ADVM

EcoR1 Capital’s Adverum Biotechnologies ADVM Stock Holding History

EcoR1 Capital’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-104,670
Closed -$1.26M – 77
2022
Q2 		$1.26M Hold
104,670
– – 0.04% 68
2022
Q1 		$1.37M Hold
104,670
– – 0.04% 72
2021
Q4 		$1.84M Buy
+104,670
New +$2.1M 0.06% 60
2017
Q4 		– Sell
-76,295
Closed -$2.79M – 32
2017
Q3 		$2.79M Sell
76,295
-11,150
-13% -$309K 0.37% 30
2017
Q2 		$2.19M Hold
87,445
– – 0.39% 27
2017
Q1 		$2.36M Hold
87,445
– – 0.6% 20
2016
Q4 		$2.54M Sell
87,445
-7,181
-8% -$235K 0.81% 18
2016
Q3 		$3.89M Buy
+94,626
New +$3.59M 1.19% 23

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EcoR1 Capital's ADVM Position: Q3 2022 in Review

EcoR1 Capital sold out of Adverum Biotechnologies (ADVM) in Q3 2022, closing a stake of 104,670 shares — an estimated $1.26M sold.

EcoR1 Capital first reported a position in ADVM in Q3 2016 and held it in 8 quarters. The position peaked at $3.89M in Q3 2016. 78 funds tracked by Wall St. Rank hold ADVM as of Q3 2022.

  • EcoR1 Capital reported no remaining Adverum Biotechnologies position as of Q3 2022 after selling out during the quarter.
  • EcoR1 Capital sold 104,670 Adverum Biotechnologies shares in Q3 2022, an estimated $1.26M.
  • EcoR1 Capital first reported a position in Adverum Biotechnologies in Q3 2016 and held it in 8 quarters.
  • EcoR1 Capital's Adverum Biotechnologies position peaked at $3.89M in Q3 2016.
  • 78 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2022.

Based on EcoR1 Capital's 13F filing for Q3 2022, filed 14 Nov 2022.